PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Neuroscience Mental Health and Sensory Organs (NESMOS), University Sapienza of Rome,Italy.\', \'Synaptic Immunopathology Lab, IRCCS San Raffaele Pisana, 00166 Rome,Italy.\', \'Physiology and Pharmacology, University Sapienza of Rome.\', \'Physiology and Pharmacology, University Sapienza of Rome | IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.\', \'Multiple Sclerosis Center, ASST Ospedali Civili, Brescia,Italy.\', \'Departments of Neuroscience Mental Health and Sensory Organs (NESMOS),University Sapienza of Rome,Italy | IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.\', \'Department of Systems Medicine, Tor Vergata University, 00133 Rome,Italy | IRCCS Neuromed, Pozzilli (Is), 86077 Pozzilli, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2174/1570159X19666210330094017
?:hasPublicationType
?:journal
  • Current neuropharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33784961
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.21
?:rankingScore_hIndex
  • 53
is ?:relation_isRelatedTo_publication of
?:title
  • Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33784961>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33784961>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all